We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Medgenics(Regs) | LSE:MEDG | London | Ordinary Share | COM SHS USD0.0001 (REGS) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 302.50 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
Medgenics, Inc.
('Medgenics' or the 'Company')
30 June 2008
The Board of Medgenics announces that on 25 June 2008 Lord Leonard Steinberg (a Director of the Company) informed
the Company that on 25 June 2008 he acquired in the market 100,000 ordinary shares of US$ 0.0001
each in the Company at a price of 5.5 pence per ordinary share.
Lord Steinberg's total interest in shares following this purchase is 14,584,725 Ordinary Shares of US$ 0.0001
each representing 13.7% of the issued share capital.
For further information, contact:
Medgenics, Inc. +972 4 958 8555
Dr. Andrew L. Pearlman
Blomfield Corporate Finance +44 207 489 4500
James Pinner or
Alan MacKenzie
SVS Securities plc +44 207 638 5600
Peter Manfield or
Ian Callaway
Citigate Dewe Rogerson +44 207 638 9571
Jonathan Shillington or
Mark Swallow or
Chris Gardner
1 Year Medgenics(Regs) Chart |
1 Month Medgenics(Regs) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
